病理确诊的路易体痴呆或阿尔茨海默病患者对碎片字母的感知
研究纳入轻度至中度痴呆患者42例和认知健康对照22例,进行碎片字母测试(字母随机视觉降解70%)。尸检确诊路易体痴呆19例(均伴阿尔茨海默病)和单纯阿尔茨海默病23例。路易体痴呆患者碎片字母测试表现差于阿尔茨海默病患者和健康对照,该测试可有效区分两者,并与α-突触核蛋白病理密度负相关。
要点
- 路易体痴呆患者碎片字母测试表现差于阿尔茨海默病患者(B=-2.80±0.91,p=0.009)和健康对照(B=-3.34±1.09,p=0.01)。
- 碎片字母测试区分路易体痴呆与阿尔茨海默病的敏感度73%、特异度87%,受试者工作特征曲线下面积0.85(95%CI 0.72-0.95)。
- 碎片字母测试得分与海马和新皮层路易体病理密度评级呈负相关(Spearman rs=-0.53至-0.69)。
核心结论
- 碎片字母测试能有效区分轻度至中度痴呆阶段的路易体痴呆病理与单纯阿尔茨海默病病理,即使路易体痴呆伴显著阿尔茨海默病病理。
- 碎片字母测试可能有助于评估路易体痴呆患者皮层α-突触核蛋白病理的严重程度。
研究设计与样本
- 研究纳入轻度至中度痴呆患者42例和认知健康对照22例,进行碎片字母测试、视空间和情景记忆测试。
- 尸检确诊痴呆病例为路易体痴呆19例(均伴阿尔茨海默病)或单纯阿尔茨海默病23例,并对海马和新皮层α-突触核蛋白病理严重程度进行序数量表评级。
主要发现
- 调整年龄、性别、教育、简易精神状态检查评分和完整字母命名能力后,路易体痴呆患者碎片字母测试表现差于阿尔茨海默病患者(B=-2.80±0.91,p=0.009)和健康对照(B=-3.34±1.09,p=0.01)。
- 阿尔茨海默病患者与健康对照无显著差异(B=-0.55±1.08,p=0.87)。
- 碎片字母测试区分路易体痴呆与阿尔茨海默病的敏感度73%、特异度87%,受试者工作特征曲线下面积0.85(95%CI 0.72-0.95)。
- 碎片字母测试的曲线下面积高于积木设计测试(0.72;CI 0.35-0.75)和加利福尼亚词语学习测试第1-5次试验(0.55;CI 0.57-0.88)。
- 碎片字母测试得分与海马和新皮层区域路易体病理密度评级呈负相关(Spearman rs=-0.53至-0.69)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Patients with dementia with Lewy bodies perform worse than those with Alzheimer disease (AD) on tests of visual perception, but the clinical utility of these tests remains unknown because studies often had clinically diagnosed groups that may inadvertently cross-contaminate Lewy body disease (LBD) with pure AD pathology, used experimental tests not easily adaptable for clinical use, and had no way to examine relationships between the severity of LBD pathology and degree of cognitive impairment. Therefore, we sought to determine whether performance on a widely used clinical test of visuoperceptual ability effectively differentiates between patients with autopsy-confirmed LBD or AD and correlates with the severity of LBD pathology. METHODS: Patients with mild to moderate dementia (n = 42) and cognitively healthy controls (n = 22) performed a Fragmented Letters Test in which they identified letters of the alphabet that were randomly visually degraded by 70% and additional visuospatial and episodic memory tests. At autopsy, dementia cases were confirmed to have LBD (n = 19), all with concomitant AD, or only AD (n = 23). Severity of α-synuclein pathology in the hippocampus and neocortex was rated on an ordinal scale. RESULTS: Patients with LBD performed worse than those with AD (B = -2.80 ± 0.91, p = 0.009) and healthy controls (B = -3.34 ± 1.09, p = 0.01) on the Fragmented Letters Test after adjustment for age, sex, education, Mini-Mental State Examination score, and ability to name intact letters. Patients with AD did not differ from controls (B = -0.55 ± 1.08, p = 0.87). The test effectively distinguished between patients with LBD or AD with 73% sensitivity and 87% specificity, and the area under the curve in receiver operating characteristic analyses was 0.85 (95% CI 0.72-0.95), higher than for standard tests of visuospatial ability (Block Design; 0.72; CI 0.35-0.75) or memory (California Verbal Learning Test, trials 1-5; 0.55; CI 0.57-0.88). Fragmented Letters Test scores were negatively correlated with LBD pathology density ratings in hippocampus and neocortical regions (Spearman rs = -0.53 to -0.69). DISCUSSION: Fragmented Letters Test performance can effectively differentiate patients with LBD pathology from those with only AD pathology at a mild to moderate stage of dementia, even when LBD occurs with significant concomitant AD pathology, and may also be useful for gauging the severity of cortical α-synuclein pathology in those with LBD.
引用
- Salmon DP, Smirnov DS, Coughlin DG, et al. Perception of Fragmented Letters by Patients With Pathologically Confirmed Dementia With Lewy Bodies or Alzheimer Disease. Neurology. 2022. PMID: 36028327. doi:10.1212/WNL.0000000000201068
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。